📰 Cardiac Resynchronization News
Cardiac Resynchronization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cardiac Resynchronization. Real-time updates on events, politics, business and more.
December 8, 2023
According to the report published by Allied Market Research, the global defibrillator market generated $13.16 billion in 2020, and is expected to reach $24.60 billion by 2030, witnessing a CAGR of 6.6% from 2021 to 2030.The study analyzes the important strategies, drivers, competition, market dynamics, size, and imp...
October 18, 2023
1. All-cause mortality after 5 years was similar for patients in the adaptive and conventional CRT groups. 2. System-related adverse events exhibited no significant disparity between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Cardiac resynchronization therapy (CRT) is the standard of care among patients with decompensated heart failure and left bundle branch block. However,
May 17, 2023
Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans
January 24, 2023
The Business Research Companys Defibrillator Devices And Equipment Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032
December 9, 2022
The Business Research Company’s Defibrillator Devices And Equipment Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
May 5, 2022
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator,...
March 17, 2022
Que Dallara joins as EVP & President, Diabetes Mike Marinaro named President, Surgical Robotics Dr. Kweli Thompson named President, Cardiac Rhythm Management DUBLIN, March 17, 2022 /PRNewswire/... | March 17, 2022
March 17, 2022
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced leadership transitions for three of its Operating Units –...
March 4, 2022
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Cardiac Resynchronization Therapy Market Size, Share & Trends Analysis Report by Product...
June 17, 2021
Bavarian Nordic, BioCryst Pharmaceuticals, Integrated Biotherapeutics, Geovax, Batavia Biosciences, Globavir Biosciences, Collaboration Pharmaceuticals, Emergex Vaccines, ReiThera, Emergent BioSolutions, Mapp Biopharmaceuticals, Biofactura, Alkido Pharma, Flow Pharma, and others are developing potential drug candidates to improve the Marburg Virus Disease treatment scenario. BioCryst is developing galidesivir in partnership with U.S. government agencies and other institutions. In September ...